[go: up one dir, main page]

AU2683492A - Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl - Google Patents

Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl

Info

Publication number
AU2683492A
AU2683492A AU26834/92A AU2683492A AU2683492A AU 2683492 A AU2683492 A AU 2683492A AU 26834/92 A AU26834/92 A AU 26834/92A AU 2683492 A AU2683492 A AU 2683492A AU 2683492 A AU2683492 A AU 2683492A
Authority
AU
Australia
Prior art keywords
glycyrrhizinate
benzyl alcohol
calcitonin
composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26834/92A
Other languages
English (en)
Inventor
Laura Chiodini
Teodoro Fonio
Mario Pinza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline SpA
Original Assignee
Smithkline Beecham Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farmaceutici SpA filed Critical Smithkline Beecham Farmaceutici SpA
Publication of AU2683492A publication Critical patent/AU2683492A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU26834/92A 1991-10-11 1992-10-08 Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl Abandoned AU2683492A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI91A2703 1991-10-11
ITMI912703A IT1251685B (it) 1991-10-11 1991-10-11 Composizioni farmaceutiche contenenti una calcitonina

Publications (1)

Publication Number Publication Date
AU2683492A true AU2683492A (en) 1993-05-03

Family

ID=11360856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26834/92A Abandoned AU2683492A (en) 1991-10-11 1992-10-08 Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl

Country Status (9)

Country Link
EP (1) EP0607229A1 (it)
JP (1) JPH07500099A (it)
AU (1) AU2683492A (it)
BR (1) BR9206707A (it)
CA (1) CA2120755A1 (it)
IT (1) IT1251685B (it)
MX (1) MX9205852A (it)
PT (1) PT100946A (it)
WO (1) WO1993006854A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2285921A (en) * 1994-01-31 1995-08-02 Leilani Lea Sublingual administration of medicaments
EP0726075A1 (en) * 1995-02-08 1996-08-14 Therapicon Srl Pharmaceutical non-inorganic saline solutions for endonasal administration
AU1808897A (en) * 1995-12-13 1997-07-03 Dullatur Limited A calcitonin preparation
IT1294191B1 (it) * 1997-09-05 1999-03-22 Alfa Wassermann Spa Composizioni farmaceutiche contenenti calcitonina in un dosatore spray per somministrazione intranasale.
GB2368792A (en) 2000-10-06 2002-05-15 Roger Randal Charles New Absorption enhancers
ITRM20010048A1 (it) * 2001-01-30 2002-07-30 Gregorio Mauro De Metodo per preparare soluzioni acquose fisiologicamente accettabili esoluzioni cosi' ottenute.
GB0308732D0 (en) * 2003-04-15 2003-05-21 Axcess Ltd Absorption enhancers
GB0308734D0 (en) 2003-04-15 2003-05-21 Axcess Ltd Uptake of macromolecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188315A (ja) * 1984-03-07 1985-09-25 Yamanouchi Pharmaceut Co Ltd グリチルレチン酸配合鎮痒プラスター
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
JPH078806B2 (ja) * 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤

Also Published As

Publication number Publication date
PT100946A (pt) 1993-10-29
JPH07500099A (ja) 1995-01-05
WO1993006854A1 (en) 1993-04-15
BR9206707A (pt) 1995-10-31
ITMI912703A1 (it) 1993-04-11
MX9205852A (es) 1993-06-01
CA2120755A1 (en) 1993-04-15
IT1251685B (it) 1995-05-19
ITMI912703A0 (it) 1991-10-11
EP0607229A1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
EP0665755B1 (en) Preparation of pharmaceutical compositions containing a calcitonin
EP0397447B1 (en) Pharmaceutical compositions
EP0327756B1 (en) Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer
JP7670749B2 (ja) Ｎａｓｈおよびその他障害の処置用の改善されたペプチド薬剤
US10052333B2 (en) Methods and systems for the delivery of a therapeutic agent
AU617157B2 (en) Intravaginal delivery of biologically active polypeptides
JP4716987B2 (ja) 骨関節症におけるカルシトニンの使用
EP0566135A1 (en) Transmucosal composition comprising a peptide and a cytidine derivative
JPH07103043B2 (ja) カルシトニン組成物およびその用途
EP3150230A1 (en) Methods and compositions for the delivery of a therapeutic agent
AU2683492A (en) Pharmaceutical compositions comprising a calcitonin, a glycyrrhizinate as absorption enhancer and benzyl
CA1329764C (en) Pharmaceutical compositions
CN119968205A (zh) 口服多肽组合物及其用途